# Champions Oncology (CSBR) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/CSBR
## Company Profile
- Ticker: CSBR
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology
## Stock Data
- Close: 5.22 USD
- Market cap: 79502078.85 USD
- Last updated: 2026-09-04
## Business Overview
Champions Oncology is a precision-oncology company focused on tumor profiling and translational research services. Its business helps pharmaceutical companies and researchers study how cancer behaves.
## Why The Stock Is Moving

As of Sep 4, 2026, CSBR closed down 1.14% at $5.22. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, Champions sits in oncology services and diagnostics.

## Business Model

The company depends on research demand, service adoption, and the monetization of its tumor-sampling and analytics platform.

## Landscape Position

Champions is a diagnostics-and-services name rather than a classic drug-development biotech.

## Future Catalysts

- Champions Oncology’s catalysts are translational oncology services, data-platform growth, and whether the business can keep scaling its research workflow. The market will watch recurring demand more than binaries.

## Recent News
- 2014-01-02 21:00 EST — [Champions Oncology Receives Accreditation From The Joint Commission](https://biopharmsignal.com/news/CSBR/champions-oncology-receives-accreditation-from-the-joint-commission-5aaf32a7) — Source: Champions Oncology
- 2013-12-12 21:00 EST — [Champions Oncology Reports Results for the Quarter Ended October 31, 2013](https://biopharmsignal.com/news/CSBR/champions-oncology-reports-results-for-the-quarter-ended-october-31-2013-23451930) — Source: Champions Oncology
- 2013-12-10 22:00 EST — [Champions Oncology to Announce Second Quarter Financial Results on December 12](https://biopharmsignal.com/news/CSBR/champions-oncology-to-announce-second-quarter-financial-results-on-december-12-6315d78f) — Source: Champions Oncology
- 2013-12-10 21:00 EST — [Enrollment Commenced in Barnabas Health and Champions Oncology Breast Cancer Research Trial](https://biopharmsignal.com/news/CSBR/enrollment-commenced-in-barnabas-health-and-champions-oncology-breast-cancer-res-e3920f12) — Source: Champions Oncology
- 2013-09-25 11:00 EST — [Champions Oncology to Present at the Aegis Capital Corp. 2013 Healthcare Conference](https://biopharmsignal.com/news/CSBR/champions-oncology-to-present-at-the-aegis-capital-corp-2013-healthcare-conferen-6d105484) — Source: Champions Oncology